Table 5. . Nausea and vomiting: assessment and management.
Prevention | – Patient education including dietary advice |
– Mint or ginger taken as a tea or capsule | |
Nausea severity†: | |
– Grade 1 | – Loss of appetite without alteration in eating habits |
– Grade 2‡ | – Oral intake decreased without significant weight loss, dehydration or malnutrition; iv. fluids indicated <24 h |
– Grade 3§ | – Inadequate oral caloric or fluid intake; iv. fluids, tube feedings or TPN indicated ≥24 h |
– Grade 4 | – |
– Grade 5 | – |
Vomiting severity† | |
– Grade 1¶ | – 1 episode in 24 h |
– Grade 2# | – 2–5 episodes in 24 h; iv. fluids indicated <24 h |
– Grade 3†† | – ≥6 episodes in 24 h; iv. fluids, or TPN indicated ≥24 h |
– Grade 4‡‡ | – Life-threatening consequences |
– Grade 5 | – Death |
Reactive management | – Antiemetic supportive care: |
• Glucocorticoids; anti-histamines or 5-HT3 receptor antagonists | |
– Adequate fluid intake | |
Nintedanib dose interruption required | – Vomiting ≥grade 2 |
and/or | |
– Nausea ≥grade 3 despite antiemetic treatment |
†Defined according to Common Terminology Criteria for Adverse Events (CTCAE) v3.0 used in the LUME-Lung 1 study, which differed slightly from the most recent version (v4.03) in the definitions as follows:
‡For grade 2 nausea, iv. fluids indicated <24 h is excluded as part of the definition, as per CTCAE v4.03;
§For grade 3 nausea, iv. fluids and TPN indicated ≥24 h are excluded as part of the definition, as per CTCAE 4.03;
¶Grade 1 vomiting is defined as 1–2 episodes (separated by 5 min) in 24 h;
#Grade 2 vomiting is defined as 3–5 episodes (separated by 5 min) in 24 h;
††Grade 3 vomiting is defined as ≥6 episodes (separated by 5 min) in 24 h; tube feeding, TPN or hospitalization indicated;
‡‡Grade 4 vomiting is defined as life-threatening consequences; urgent intervention indicated.
iv.: Intravenous; TPN: Total parenteral nutrition.
Data taken from [6].